Form 4 for OTIS Otis Worldwide
Accepted 2025-02-05 00:00:00 ET · period of report 2025-02-03 · accession 0001062993-25-001785 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-05 | 2025-02-03 | OTIS | Zheng Peiming | EVP, Chief Product, Delivery | M - OptEx | — | +1,280 | 1,449 | +757% | — |
| DM | 2025-02-05 | 2025-02-03+ | OTIS | Zheng Peiming | EVP, Chief Product, Delivery | F - Tax | $94.45 | -3,756 | 4,577 | -45% | -$354.7K |
| D | 2025-02-05 | 2025-02-04 | OTIS | Zheng Peiming | EVP, Chief Product, Delivery | A - Grant | — | +6,884 | 7,769 | +778% | — |
| D | 2025-02-05 | 2025-02-04 | OTIS | Zheng Peiming | EVP, Chief Product, Delivery | A - Grant | $0.00 | +9,585 | 9,585 | New | $0 |
| D | 2025-02-05 | 2025-02-03 | OTIS | Zheng Peiming | EVP, Chief Product, Delivery | M - OptEx | $0.00 | -1,280 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-03 | M | A | 1,280 | — | 1,449 | D | — | — | (F1) Restricted stock units (RSUs) convert into common stock on a one-for-one basis. RSUs include the right to receive dividend equivalents that are credited as additional RSUs. |
| 2 | Common | Common Stock | 2025-02-03 | F | D | 564 | $94.55 | 885 | D | — | — | |
| 3 | Common | Common Stock | 2025-02-04 | A | A | 6,884 | — | 7,769 | D | — | — | (F4) The acquisition of Otis common stock represents the vesting of performance share units (PSUs) previously awarded on February 3, 2022. Each PSU has a value equal to one share of Otis common stock. These PSUs vested on the Transaction Date upon the achievement of the 3-year cycle preestablished performance targets. The performance criteria were certified to be achieved at the 82% level. |
| 4 | Common | Common Stock | 2025-02-04 | F | D | 3,192 | $94.43 | 4,577 | D | — | — | |
| 5 | Derivative | Restricted Stock Units | 2025-02-04 | A | A | 9,585 | $0.00 | 9,585 | D | — · — to — | 9,585 Common Stock | (F1) Restricted stock units (RSUs) convert into common stock on a one-for-one basis. RSUs include the right to receive dividend equivalents that are credited as additional RSUs. (F3) RSUs vest in three substantially equal annual installments beginning on the first anniversary of the Transaction Date. |
| 6 | Derivative | Restricted Stock Units | 2025-02-03 | M | D | 1,280 | $0.00 | 0 | D | — · — to — | 1,280 Common Stock | (F1) Restricted stock units (RSUs) convert into common stock on a one-for-one basis. RSUs include the right to receive dividend equivalents that are credited as additional RSUs. (F2) On February 3, 2022, the reporting person was granted RSUs vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. The last installment vested on the Transaction Date. |